MAPT and amyloidosis: Since amyloid deposition is thought to precede synaptic dysfunction, increased cerebrospinal fluid (CSF) tau and phospho-tau levels, subtle structural changes in hippocampal volume and cortical thinning and ultimately cognitive impairment9–12, amyloid PET analysis tools should be tested in cognitively intact elderly persons.